Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension — RxCUI 252203
RxNorm drug concept · Semantic clinical drug
RxCUI 252203
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI252203
Official nameAluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asaluminum hydroxide 32 MG / magnesium carbonate 119 MG per 5 ML Oral Suspension; aluminum hydroxide 95 MG / magnesium carbonate 358 MG in 15 mL Oral Suspension; aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG per 5 ML Oral Suspension; aluminum hydroxide 95 MG / magnesium carbonate 358 MG per 15 ML Oral Suspension
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)15,873 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aluminum Hydroxide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. The oral liquid is an antacid — you take it by mouth to relieve heartburn, acid indigestion, and sour stomach. ProCure DryDrox is a completely different...
- What is aluminum hydroxide actually used for?
- Give the bottle a good shake before every use — that's important. Take 2 teaspoonfuls up to 5 to 6 times a day, after meals and at bedtime, followed by a small sip of water if you...
- How do I take the oral liquid correctly?
🕸️ Concept Web — How Aluminum hydroxide 6.33 MG/ML / magnesium carbon... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension
RxCUI 252203 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Aluminum hydroxide
612IN -
Magnesium carbonate
29155IN -
Aluminum hydroxide / magnesium carbonate
1029441MIN
-
Aluminum hydroxide
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Acid Gone
352396BN -
Gaviscon
25655BN
-
Acid Gone
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aluminum hydroxide / magnesium carbonate Oral Suspension
370832SCDF -
Aluminum hydroxide / magnesium carbonate Oral Liquid Product
1155939SCDG -
Aluminum hydroxide / magnesium carbonate Oral Product
1155940SCDG -
Aluminum hydroxide / magnesium carbonate Oral Suspension [Acid Gone]
365901SBDF -
Aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon]
366007SBDF -
Acid Gone Oral Liquid Product
1168430SBDG -
Acid Gone Oral Product
1168431SBDG -
Gaviscon Oral Liquid Product
1167118SBDG - +4 more in this family
-
Aluminum hydroxide / magnesium carbonate Oral Suspension
-
Clinical & branded drugs 6
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aluminum hydroxide 6.33 MG/ML
331000SCDC -
Magnesium carbonate 23.9 MG/ML
331001SCDC -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Acid Gone]
1251355SBD -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]
1251365SBD -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Acid Gone]
1251354SBDC -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon]
1251364SBDC
-
Aluminum hydroxide 6.33 MG/ML
Showing up to 8 concepts per family — 19 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aluminum hydroxide 6.33 MG/ML
SCDC · 331000 -
Magnesium carbonate 23.9 MG/ML
SCDC · 331001 -
Aluminum hydroxide / magnesium carbonate Oral Suspension
SCDF · 370832 -
Aluminum hydroxide / magnesium carbonate Oral Liquid Product
SCDG · 1155939 -
Aluminum hydroxide / magnesium carbonate Oral Product
SCDG · 1155940
Brand-Name Concepts
-
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Acid Gone]
SBD · 1251355 -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]
SBD · 1251365 -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Acid Gone]
SBDC · 1251354 -
Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon]
SBDC · 1251364 -
Aluminum hydroxide / magnesium carbonate Oral Suspension [Acid Gone]
SBDF · 365901 -
Aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon]
SBDF · 366007 -
Acid Gone Oral Liquid Product
SBDG · 1168430 -
Acid Gone Oral Product
SBDG · 1168431 -
Gaviscon Oral Liquid Product
SBDG · 1167118 -
Gaviscon Oral Product
SBDG · 1167119
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 252203 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00135-0094-41 | 355 mL in 1 BOTTLE (0135-0094-41) | GAVISCON | Haleon US Holdings LLC | 2011-01-14 |
| 00135-0094-42 | 177 mL in 1 BOTTLE (0135-0094-42) | GAVISCON | Haleon US Holdings LLC | 2011-01-14 |
| 00135-0095-41 | 355 mL in 1 BOTTLE (0135-0095-41) | GAVISCON | Haleon US Holdings LLC | 2011-01-14 |
| 00135-0574-01 | 355 mL in 1 BOTTLE (0135-0574-01) | GAVISCON | Haleon US Holdings LLC | 2014-08-01 |
| 00904-7727-14 | 355 mL in 1 BOTTLE (0904-7727-14) | ACID GONE ANTACID | Major Pharmaceuticals | 2017-03-01 |
Observed labelers:
Haleon US Holdings LLC (4) ·
Major Pharmaceuticals (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.